No More PSA Tests!
PSA tests are no longer recommended for men as screens for prostate cancer. Those are the new guidelines released today by the American Urological Association (AUA).
Rx May Lower Prostate Cancer Mortality
Prostate cancer is the most common cancer in men. Fortunately, it’s not a fatal cancer for most men. New research has found that one medication that’s used to lower cholesterol may also lower prostate cancer deaths.
Prostate Cancer May Prefer Big Men
Obesity increases a person’s risk of a variety of cancers. This connection now appears to affect men who have been tested for and found not to have prostate cancer.
PSA Test Outcomes Vary for Older Men
While the incidence of prostate cancer is greater in older men, the screening guidelines are murky. A new study analyzed what happened after older men were screened.
A Crystal Ball for Prostate Cancer Testing
The statistics are pretty clear that most American men are not going to die of prostate cancer. But the question remains: who should be screened and how often? A new crystal ball may be on the horizon.
One Mineral May Lower Prostate Cancer Risk
Selenium is a trace mineral that helps prevent cell damage. Studies regarding this mineral have been inconclusive. But new research suggests selenium may have anti-cancer properties.
Physician Group Recommends Against PSA Tests
If you’re a man – or a woman for that matter – you’re probably confused about cancer screenings. The recommendations for prostate cancer screenings have been all over the place.
Breaks From Cancer Therapy Don’t Give Men a Break
Men with advanced prostate cancer usually take medicines to keep the disease at bay. These medications block male hormones that feed the cancer. New research evaluated the best way to take these medications.
Bald is Beautiful, But Beware
Baldness affects about 60 percent of men at some time in their lives. Researchers now think baldness and prostate cancer may be linked in African American men.
Cancer Spreads in Zometa Study
Many cancer patients take medications to prevent the disease from returning or spreading. One medication designed to prevent cancer from spreading to the bones fell short in a recent study.